XYQ-22107-54012
2 vaccinations
5 coded responses
24 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 630 / MO
- Registered
- 2021-02-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-04
Dose 1 — Pfizer-BioNTech
-
2021-02-05
Registered in v-safe
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-20
-
2021-02-25
Dose 2 — Pfizer-BioNTech
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-02-28
-
2021-03-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-11
-
2021-03-18
Survey response — 21 day, dose 2MedDRA: Fatigue, Gastrooesophageal reflux disease, Hospitalisation, Syncope, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-03-18
Report sent to call center — 21 day, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-25
-
2021-04-01
Survey response — 35 day, dose 2MedDRA: Cardiac disorder — Feeling: GoodMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-04-08
Survey response — 42 day, dose 2MedDRA: Chills, Fatigue — Feeling: FairMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-05-27
-
2021-08-26
Survey response — 6 month, dose 2MedDRA: Oropharyngeal pain, SARS-CoV-2 test negative — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2024-11 · check-in answers available
- 2021-10-21
-
2022-02-25
Survey response — 12 month, dose 2MedDRA: Angina pectoris — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-04 | Pfizer-BioNTech | |
| 2 | 2021-02-25 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-18 | Unsuccessful |
Free text
Release 5
Symptoms: Admitted to hospital with symptoms hinting at heart attack. Diagnosed as Gerd and syncope with collapse. Released on Saturday, March 13. Still feeling very tired.
Healthcare visit (other): See above.
Release 6
Symptoms: Wearing a Nitro patch and taking Entresto for heart condition
Release 7
Symptoms: Strange sensation of "chills." Started since I had the vaccine but I never thought to report it before. I am tired a lot. The thought of taking a walk wears me out.
Release 9
Symptoms: Very sore throat lasting five days. Tested negative for covid.
Release 11
Symptoms: Angina
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Angina pectoris | · | · | ✓ |
| SD | Cardiac disorder | ✓ | ✓ | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Gastrooesophageal reflux disease | ✓ | ✓ | ✓ |
| SD | Hospitalisation | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | · | ✓ |
| SD | Syncope | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release